← Open Payments lookup

MARIANA FAYMAN: Open Payments

NPI 1386745909 · BEVERLY HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,169 in 60 payments from 7 companies in 2025. Trend: 2023 $760 · 2024 $1,229 · 2025 $1,169

Food & beverage: $1,169
CompanyPaymentsAmount
ABBVIE INC.28$500
GENZYME CORPORATION5$209
Salix Pharmaceuticals, a division of Bausch Health US, LLC15$206
Janssen Biotech, Inc.5$124
Ardelyx, Inc.3$56
Celltrion USA Inc.3$53
Phathom Pharmaceuticals, Inc.1$20

Products named: DUPIXENT, RINVOQ, XIFAXAN, LINZESS, TREMFYA, CREON, IBSRELA, VEGZELMA.

Industry payments across CA — which companies pay providers there.